Literature DB >> 12658779

Increased expression of endothelin receptors in human cirrhosis--relationship with splanchnic hemodynamics.

Xiaorong Deng1, Zhen Yang.   

Abstract

The purpose of the present study was to assess the correlation that likely exists among increased portal pressure (Pp), portal blood flow quantity (Qp) and ETA and ETB receptor mRNA expression in human cirrhosis. In situ hybridization and reverse-transcription polymerase chain reactions (RT-PCR) were performed to determined the expression of ETA and ETB receptor mRNA in liver tissues from traumatic subjects (n = 10) and cirrhotic patients (n = 15) in whom hepatic hemodynamic values were measured. The expression of the two transcripts was significantly higher in liver samples of cirrhotic patients than in those obtained from traumatic subjects. It has shown that ETA receptor mRNA predominantly located in hepatic stellate cells (HSCs) and vascular smooth muscle cells of intrahepatic arteries and portal veins, ETB receptor mRNA in HSCs, sinusoidal endothelial cells and Kuppfer cells. There was a highly significant direct relationship between ETA and ETB receptor mRNA and Pp and Qp in cirrhotic patients. It suggests that liver paracrine endothelin system may be overactivated in human cirrhosis accompanied with increased expression of ETA and ETB receptor mRNA which may play an important role in the pathogenesis and maintenance of splanchnic hyperdynamics.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12658779     DOI: 10.1007/BF02904784

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  17 in total

1.  Molecular cloning of a non-isopeptide-selective human endothelin receptor.

Authors:  Y Ogawa; K Nakao; H Arai; O Nakagawa; K Hosoda; S Suga; S Nakanishi; H Imura
Journal:  Biochem Biophys Res Commun       Date:  1991-07-15       Impact factor: 3.575

2.  Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients.

Authors:  M Pinzani; P Failli; C Ruocco; A Casini; S Milani; E Baldi; A Giotti; P Gentilini
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

Review 3.  Endothelin receptors: receptor classification, novel receptor antagonists, and potential therapeutic targets.

Authors:  E H Ohlstein; J D Elliott; G Z Feuerstein; R R Ruffolo
Journal:  Med Res Rev       Date:  1996-07       Impact factor: 12.944

4.  Increased hepatic endothelin-1 levels and endothelin receptor density in cirrhotic rats.

Authors:  C R Gandhi; L A Sproat; V M Subbotin
Journal:  Life Sci       Date:  1996       Impact factor: 5.037

Review 5.  Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies.

Authors:  S L Friedman
Journal:  N Engl J Med       Date:  1993-06-24       Impact factor: 91.245

6.  Role of endothelin in the increased vascular tone of patients with essential hypertension.

Authors:  C Cardillo; C M Kilcoyne; M Waclawiw; R O Cannon; J A Panza
Journal:  Hypertension       Date:  1999-02       Impact factor: 10.190

7.  Coupling of endothelin B receptors to the calcium pump and phospholipase C via Gs and Gq in rat liver.

Authors:  C Jouneaux; A Mallat; C Serradeil-Le Gal; P Goldsmith; J Hanoune; S Lotersztajn
Journal:  J Biol Chem       Date:  1994-01-21       Impact factor: 5.157

8.  Endothelin antagonism in experimental hepatic fibrosis. Implications for endothelin in the pathogenesis of wound healing.

Authors:  D C Rockey; J J Chung
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

9.  Plasma endothelin levels in cirrhotic subjects.

Authors:  F Veglio; G Pinna; R Melchio; F Rabbia; M Panarelli; B Gagliardi; L Chiandussi
Journal:  J Hepatol       Date:  1992-05       Impact factor: 25.083

10.  Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin 1.

Authors:  C Housset; D C Rockey; D M Bissell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.